PHS
MYOV

PFM Health Sciences’s Myovant Sciences Ltd. MYOV Stock Holding History

PFM Health Sciences’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-411,500
Closed -$11.4M – 110
2020
Q4 		$11.4M Buy
+411,500
New +$8.01M 0.4% 68

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PFM Health Sciences's MYOV Position: Q3 2021 in Review

PFM Health Sciences sold out of Myovant Sciences Ltd. (MYOV) in Q3 2021, closing a stake of 1,912,188 shares — an estimated $43.5M sold.

PFM Health Sciences first reported a position in MYOV in Q3 2020 and held it in 4 quarters. The position peaked at $43.5M in Q2 2021. 105 funds tracked by Wall St. Rank hold MYOV as of Q3 2021.

  • PFM Health Sciences reported no remaining Myovant Sciences Ltd. position as of Q3 2021 after selling out during the quarter.
  • PFM Health Sciences sold 1,912,188 Myovant Sciences Ltd. shares in Q3 2021, an estimated $43.5M.
  • PFM Health Sciences first reported a position in Myovant Sciences Ltd. in Q3 2020 and held it in 4 quarters.
  • PFM Health Sciences's Myovant Sciences Ltd. position peaked at $43.5M in Q2 2021.
  • 105 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2021.

Based on PFM Health Sciences's 13F filing for Q3 2021, filed 15 Nov 2021.